Li B, Han Y, Sun C, Shi M, et al. Risk of type 2 inflammation-related diseases during Interleukin-17-inhibitors treatment for psoriasis patients-A retrospective cohort study. Br J Dermatol 2026 May 16:ljag186. doi: 10.1093.
PMID: 42141899